• NORTH CAROLINA SOCIETY OF GASTROENTEROLOGY
  • 704.376.3688
  • sbuchanan@meckmed.org
NCSGlogo-300NCSGlogo-only-150NCSGlogo-300NCSGlogo-300
  • Home
  • Events and Education
  • Research
  • About NCSG
    • Board of Directors
    • Board Meetings
    • Grants
    • Partners
    • NCSG Bylaws
JOIN or RENEW HERE
✕
Categories
  • Intraductal Papillary Mucinous Neoplasms
Tags
  • Intraductal Papillary Mucinous Neoplasms (IPMN)
Study title The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial)
Disease or condition High risk intraductal papillary mucinous neoplasms (IPMNs)
Study type Interventional (Clinical Trial)
Intervention/treatment Sulindac or placebo
Phase 2
Study site Duke University
Study location Durham, NC
Principal investigator Joshua Spaete, MD
Study coordinator Beth Bronoson; Elizabeth.bronson@duke.edu
Phone contact 919-668-2382
Clinicaltrials.gov link https://clinicaltrials.gov/ct2/show/NCT04207944

ADDRESS


1112 Harding Place
Suite 100
Charlotte NC 28204

Fax: 704.376.3173

LINKS


Home
Education
Events
Research
JOIN NOW

CONTACT


704.376.3688
sbuchanan@meckmed.org

Copyright: North Carolina Society of Gastroenterology (NCSG)
JOIN or RENEW HERE